Search clinical trials for: Trastuzumab SC
Total 1643 results
-
Thomas HatschekActive, not recruitingEarly-Stage Breast Carcinoma | HER-2 Positive Breast CancerSweden
-
Hoffmann-La RocheCompletedHER2-Positive Early Breast CancerUnited States, Finland, Hong Kong, Panama, Portugal, Spain, Mexico, Sweden, Brazil, Serbia, Argentina, Lebanon, Cuba, Qatar, Saudi Arabia, Chile, Jordan
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruitingHER2-positive Breast Cancer | Early-stage Breast Cancer | Adjuvant Treatment After Trastuzumab | RCB Classification 1-2 | NeratiniChina
-
Hoffmann-La RocheCompleted
-
Samsung Bioepis Co., Ltd.CompletedHER2 Positive Early or Locally Advanced Breast CancerCzechia
-
PfizerCompleted
-
Genentech, Inc.Approved for marketing
-
Jules Bordet InstituteHoffmann-La Roche; Breast International Group; Institut Curie; International Drug...SuspendedHER2-positive Breast Cancer | ER-Negative Breast Cancer | PR-Negative Breast Cancer | Node-negative Breast CancerKorea, Republic of, France, Israel, Belgium, Switzerland, Australia
-
Innovent Biologics (Suzhou) Co. Ltd.CompletedHypercholesterolemiaChina
-
University of California, San DiegoUniversity of Oklahoma; University of Southern California; Children's Bureau... and other collaboratorsCompletedInterpersonal RelationsUnited States
-
StemCells, Inc.TerminatedStudy of Human Central Nervous System (CNS) Stem Cell Transplantation in Cervical Spinal Cord InjuryCervical Spinal Cord Injury | Spine Injury | Cervical Spine InjuryUnited States, Canada
-
argenxActive, not recruitingPrimary Immune ThrombocytopeniaUnited States, France, Georgia, Germany, Italy, Japan, Poland, Russian Federation, Spain, Turkey, United Kingdom, Argentina, Australia, Bulgaria, Chile, China, Denmark, Greece, Ireland, Israel, Jordan, Korea, Republic of, Mexico, New... and more
-
argenxRecruitingThyroid Eye DiseaseUnited States
-
Dana-Farber Cancer InstituteGenentech, Inc.Recruiting
-
MedSIRHoffmann-La RocheActive, not recruitingEarly Breast CancerSpain, Italy, Germany, Bulgaria, Hungary
-
Gruppo Oncologico Italiano di Ricerca ClinicaMipharm SpA; Temas srl; Clirest s.r.l.; University Hospital of Parma: Department... and other collaboratorsUnknown
-
Federal University of Health Science of Porto AlegreIrmandade Santa Casa de Misericórdia de Porto AlegreUnknownGynecologic Cancer | Pathological ConstrictionBrazil
-
argenxRecruitingThyroid Eye DiseaseUnited States
-
Eli Lilly and CompanyCompleted
-
Hangzhou Sumgen Biotech Co., Ltd.RecruitingSystemic Lupus Erythematosus (SLE)China
-
Eli Lilly and CompanyCompleted
-
Jonsson Comprehensive Cancer CenterCompletedBreast CancerUnited States
-
GlaxoSmithKlineCompletedAsthmaUnited States, Argentina, Australia, Canada, France, Germany, Japan, Russian Federation, Spain, Ukraine, Belgium, Chile, Korea, Republic of, Mexico, Italy, United Kingdom
-
argenxRecruitingPrimary Immune ThrombocytopeniaUnited States, Australia, Bulgaria, China, Georgia, Greece, Italy, Japan, Poland, Portugal, Romania, Russian Federation, Thailand, Turkey, Argentina, Chile, Ireland, Jordan, Tunisia, Korea, Republic of, Mexico, New Zealand, South Africa and more
-
Implandata Ophthalmic Products GmbHCRO Dr. med. Kottmann GmbH & Co. KGActive, not recruitingGlaucoma | Open Angle GlaucomaGermany, Switzerland
-
Mitchell ScheimanChildren's Hospital of Philadelphia; University of Alabama at Birmingham; Boston... and other collaboratorsNot yet recruitingConcussion | Convergence InsufficiencyUnited States
-
BiogenCompletedHealthy | Painful Lumbar RadiculopathyNetherlands
-
Eli Lilly and CompanyCompleted
-
BayerRecruitingPulmonary Hypertension Due to Left Heart DiseaseGermany
-
Alexion Pharmaceuticals, Inc.Syneos HealthCompleted
-
Eli Lilly and CompanyCompleted
-
ViiV HealthcareGlaxoSmithKlineNot yet recruiting
-
Hoffmann-La RochePfizerCompletedModerate to Severe Ulcerative ColitisUnited States, Australia, Thailand, Poland, Russian Federation, Japan, Colombia, Spain, Turkey, Romania, India, Slovakia, France, Hungary, South Africa, Belgium, Bulgaria, Germany, Italy, Mexico, Serbia, Ukraine, United Kingdom
-
Hoffmann-La RocheActive, not recruitingInflammatory Breast Cancer | Early Breast Cancer | Locally Advanced Breast CancerCanada, Croatia, Spain, Argentina, Mexico, Korea, Republic of, Bosnia and Herzegovina, Brazil, Costa Rica, Turkey, Singapore, Bulgaria, South Africa, India, Peru, Kenya, Chile
-
Immunovant Sciences GmbHRecruitingGeneralized Myasthenia GravisUnited States, Poland, Romania, Italy, Georgia, Korea, Republic of, Canada, Japan, Hungary, Spain, Serbia, Germany
-
Hoffmann-La RocheCompletedEarly Breast CancerFrance, Spain, United States, Korea, Republic of, Canada, United Kingdom, Argentina, Belgium, Germany, Italy, Taiwan, Thailand, Japan, Brazil, Mexico, Czechia, Poland, Russian Federation, Ukraine
-
StemcentrxTerminatedOvarian CancerUnited States
-
Alexion PharmaceuticalsCompletedHealthyUnited Kingdom
-
AbbVieTerminated
-
MedSIRHoffmann-La RocheNot yet recruiting
-
Henan Cancer HospitalRecruitingBreast Cancer | HER2-positive Breast CancerChina
-
Regeneron PharmaceuticalsCompletedHomozygous Familial HypercholesterolemiaUnited States, Netherlands, Canada
-
Astria Therapeutics, Inc.Completed
-
Eli Lilly and CompanyTerminatedPsoriasisUnited States, Canada
-
Bausch Health Americas, Inc.Completed
-
Hoffmann-La RocheActive, not recruiting